ExpreS2ion Biotech Holding AB (”ExpreS2ion”) hereby announces on May 26th 2016 that the company is planning an Initial Public Offering during June 2016 with planned listing on Nasdaq Stockholm First North. Fully subscribed, this offering will provide revenues of 18 MSEK to ExpreS2ion.

Läs hela pressmeddelandet (pdf)
Read the whole press release (pdf)